Key Metrics
Journal Specifications
- PublisherFUTURE MEDICINE LTD
- LanguageEnglish
- FrequencySemi-monthly
- LanguageEnglish
- FrequencySemi-monthly
- Publication Start Year2006
- Publisher URL
- Website URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Nanomedicine been publishing?
The Nanomedicine has been publishing since 2006 till date.
How frequently is the Nanomedicine published?
Nanomedicine is published Semi-monthly.
Who is the publisher of Nanomedicine?
The publisher of Nanomedicine is FUTURE MEDICINE LTD.
How can I view the journal metrics of Nanomedicine on editage?
For the Nanomedicine metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Nanomedicine?
The eISSN number is 1748-6963 and pISSN number is 1743-5889 for Nanomedicine.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Reactive oxygen species, Lung cancer, Camptothecin, Drug delivery, Breast cancer, Nanomedicine, Assay, Doxorubicin, Bioavailability, Extracellular vesicles, Autophagy, Nanocarriers, Iron oxide nanoparticles, Tumor microenvironment, Neuroscience research, Bilirubin, Glioblastoma, Photodynamic therapy, Rheumatoid arthritis, Gemcitabine.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.